Get AG1
Sign In

Impressum

Site Operator:
Athletic Greens (EU) Limited
2 Grand Canal Square
Grand Canal Dock
Dublin 2, D02A342

Athletic Greens (UK) Limited
43 Overstone Road,
London, England, W6 0AD

Represented by the Managing Director:
Chris Ashenden

Contact:
Phone: +49 800 7234944
Email: support.eu@drinkag1.com

VAT - IE3711383NH

Responsible for content according to § 18 Abs. 2 MStV:
Gerd Mittmann

Statement regarding European Commission's platform for online dispute resolution:
“The EU Commission has created an Internet platform for online dispute resolution. The platform serves as a contact point for the out-of-court settlement of disputes concerning contractual obligations arising from online sales contracts. More information is available at the following link: http://ec.europa.eu/consumers/odr. We are neither willing nor obliged to participate in a dispute resolution procedure before a consumer arbitration board.”

SHOP

LEARN MORE

ABOUT

CONTACT

Connect

Join Our Newsletter

© 2025 AG1

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Information on the AG1 site is provided for informational purposes only. It is not meant to substitute for medical advice from your physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease, or prescribing any medication. Carefully read all product documentation. If you have or suspect that you have a medical problem, promptly contact your regular health care provider.

** Offer valid for first time subscribers only.

Actual Packaging May Vary

  1. In a triple-blind, randomized, placebo-controlled parallel-designed clinical trial evaluating nutrient biomarkers and microbiome shifts in 105 healthy adults ages 20-59 over the course of 12 weeks.
  2. In a double-blind, randomized, placebo-controlled 2-week crossover clinical trial assessing nutrient gaps and microbiome shifts in 20 active adults ages 19-37.
  3. In a double-blind, randomized, placebo-controlled 2-week crossover clinical trial assessing nutrient gaps and microbiome assessments of 40 healthy adults with occasional GI distress ages 26-59 over the course of 4 weeks.
  4. In a double-blind, randomized, placebo-controlled crossover clinical trial assessing nutrient gaps and bioavailability in 16 healthy adults ages 18-42 over the course of 8 hours.
  5. In a third-party, single-arm, closed label interventional study of 104 healthy adults ages 25-9 assessing self-perceived efficacy of AG1 Next Gen over 3 months.

Your privacy is our priority. Learn more:  

© 2025 AG1